Safe Orthopaedics SA SAFOR Product Pipeline Analysis, 2017 Update [Report Updated: 21062017] Prices from USD $750

11:59 EDT 29 Jul 2017 | BioPortfolio Reports


Safe Orthopaedics SA Safe Orthopaedics is medical equipment company that manufactures and markets minimally invasive devices for spinal surgery. The company's product portfolio includes implants and surgical instruments. It offers modular cervical cages, percutaneous autocorrection screws, modular anchorage screws, percutaneous autocorrection screws and leaner positioning cages. Safe Orthopaedics also provides pedicle screws and lumber cage instrument kits. Its instruments are used for the treatment of trauma and degenerative pathologies. The company markets its products through a network of distributors across Europe, South America, Africa and Australia. Safe Orthopaedics is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Safe Orthopaedics SA
The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research Development strategies
Develop marketentry and market expansion strategies
Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Original Article: Safe Orthopaedics SA SAFOR Product Pipeline Analysis, 2017 Update [Report Updated: 21062017] Prices from USD $750


More From BioPortfolio on "Safe Orthopaedics SA SAFOR Product Pipeline Analysis, 2017 Update [Report Updated: 21062017] Prices from USD $750"

Quick Search

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...